PubMed:10092091
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | protein | denotes | NF-kappaB |
| T2 | 67-80 | cell_type | denotes | T lymphocytes |
| T3 | 205-225 | protein | denotes | transcription factor |
| T4 | 226-235 | protein | denotes | NF-kappaB |
| T5 | 312-315 | protein | denotes | TNF |
| T6 | 334-343 | protein | denotes | NF-kappaB |
| T7 | 374-377 | protein | denotes | Fas |
| T8 | 378-383 | protein | denotes | APO-1 |
| T9 | 384-388 | protein | denotes | CD95 |
| T10 | 424-441 | cell_type | denotes | peripheral T cell |
| T11 | 465-477 | cell_line | denotes | Jurkat cells |
| T12 | 487-505 | protein | denotes | NF-kappaB subunits |
| T13 | 506-509 | protein | denotes | p50 |
| T14 | 514-517 | protein | denotes | p65 |
| T15 | 597-606 | protein | denotes | NF-kappaB |
| T16 | 675-684 | protein | denotes | NF-kappaB |
| T17 | 696-703 | protein | denotes | IkappaB |
| T18 | 792-801 | protein | denotes | NF-kappaB |
| T19 | 855-871 | cell_line | denotes | T cell hybridoma |
| T20 | 949-952 | protein | denotes | p50 |
| T21 | 957-960 | protein | denotes | p65 |
| T22 | 1074-1077 | protein | denotes | Fas |
| T23 | 1096-1111 | cell_type | denotes | primary T cells |
| T24 | 1138-1159 | cell_line | denotes | cycling T cell blasts |
| T25 | 1198-1223 | protein | denotes | dominant IkappaB molecule |
| T26 | 1315-1334 | protein | denotes | NF-kappaB complexes |
| T27 | 1373-1376 | protein | denotes | TNF |
| T28 | 1409-1418 | protein | denotes | NF-kappaB |
| T29 | 1425-1448 | protein | denotes | neutralizing antibodies |
| T30 | 1573-1582 | protein | denotes | NF-kappaB |
| T31 | 1600-1603 | protein | denotes | Fas |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-81 | Sentence | denotes | NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes. |
| S2 | 82-200 | Sentence | denotes | The maintenance of lymphocyte homeostasis by apoptosis is a critical regulatory mechanism in the normal immune system. |
| S3 | 201-315 | Sentence | denotes | The transcription factor NF-kappaB has been shown to play a role in protecting cells against death mediated by TNF |
| S4 | 316-448 | Sentence | denotes | We show here that NF-kappaB also has a role in regulating Fas/APO-1/CD95-mediated death, a major pathway of peripheral T cell death. |
| S5 | 449-568 | Sentence | denotes | Transfection of Jurkat cells with the NF-kappaB subunits p50 and p65 confers resistance against Fas-mediated apoptosis. |
| S6 | 569-764 | Sentence | denotes | Reciprocally, inhibition of NF-kappaB activation by a soluble peptide inhibitor or a dominant form of the NF-kappaB inhibitor, IkappaB, makes the cells more susceptible to Fas-mediated apoptosis. |
| S7 | 765-915 | Sentence | denotes | Furthermore, inhibition of NF-kappaB activation by a soluble peptide inhibitor rendered a T cell hybridoma more susceptible to TCR-mediated apoptosis. |
| S8 | 916-1022 | Sentence | denotes | Correspondingly, transfection of p50 and p65 provided considerable protection from TCR-mediated apoptosis. |
| S9 | 1023-1112 | Sentence | denotes | These observations were corroborated by studies on Fas-mediated death in primary T cells. |
| S10 | 1113-1350 | Sentence | denotes | Concanavalin A-activated cycling T cell blasts from mice that are transgenic for the dominant IkappaB molecule have increased sensitivity to Fas-mediated apoptosis, associated with a down-regulation of NF-kappaB complexes in the nucleus. |
| S11 | 1351-1515 | Sentence | denotes | In addition, blocking TNF, itself a positive regulator of NF-kappaB, with neutralizing antibodies renders the cells more susceptible to anti-Fas-mediated apoptosis. |
| S12 | 1516-1698 | Sentence | denotes | In summary, our results provide compelling evidence that NF-kappaB protects against Fas-mediated death and is likely to be an important regulator of T cell homeostasis and tolerance. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-9 | NP | denotes | NF-kappaB |
| C2 | 201-235 | NP | denotes | The transcription factor NF-kappaB |
| C3 | 312-315 | NP | denotes | TNF |
| C4 | 334-343 | NP | denotes | NF-kappaB |
| C5 | 374-403 | NP | denotes | Fas/APO-1/CD95-mediated death |
| C6 | 405-447 | NP | denotes | a major pathway of peripheral T cell death |
| C7 | 465-477 | NP | denotes | Jurkat cells |
| C8 | 483-517 | NP | denotes | the NF-kappaB subunits p50 and p65 |
| C9 | 545-567 | NP | denotes | Fas-mediated apoptosis |
| C10 | 597-617 | NP | denotes | NF-kappaB activation |
| C11 | 621-648 | NP | denotes | a soluble peptide inhibitor |
| C12 | 652-694 | NP | denotes | a dominant form of the NF-kappaB inhibitor |
| C13 | 696-703 | NP | denotes | IkappaB |
| C14 | 711-720 | NP | denotes | the cells |
| C15 | 741-763 | NP | denotes | Fas-mediated apoptosis |
| C16 | 792-812 | NP | denotes | NF-kappaB activation |
| C17 | 816-843 | NP | denotes | a soluble peptide inhibitor |
| C18 | 892-914 | NP | denotes | TCR-mediated apoptosis |
| C19 | 949-960 | NP | denotes | p50 and p65 |
| C20 | 999-1021 | NP | denotes | TCR-mediated apoptosis |
| C21 | 1096-1111 | NP | denotes | primary T cells |
| C22 | 1165-1169 | NP | denotes | mice |
| C23 | 1170-1174 | NP | denotes | that |
| C24 | 1254-1276 | NP | denotes | Fas-mediated apoptosis |
| C25 | 1373-1376 | NP | denotes | TNF |
| C27 | 1378-1384 | NP | denotes | itself |
| C28 | 1409-1418 | NP | denotes | NF-kappaB |
| C26 | 1378-1418 | NP | denotes | itself a positive regulator of NF-kappaB |
| C29 | 1457-1466 | NP | denotes | the cells |
| C30 | 1548-1567 | NP | denotes | compelling evidence |
| C31 | 1568-1572 | NP | denotes | that |
| C32 | 1573-1582 | NP | denotes | NF-kappaB |
| R1 | C2 | C1 | coref-ident | The transcription factor NF-kappaB,NF-kappaB |
| R2 | C4 | C2 | coref-ident | NF-kappaB,The transcription factor NF-kappaB |
| R3 | C6 | C5 | coref-appos | a major pathway of peripheral T cell death,Fas/APO-1/CD95-mediated death |
| R4 | C13 | C12 | coref-appos | IkappaB,a dominant form of the NF-kappaB inhibitor |
| R5 | C14 | C7 | coref-ident | the cells,Jurkat cells |
| R6 | C15 | C9 | coref-ident | Fas-mediated apoptosis,Fas-mediated apoptosis |
| R7 | C16 | C10 | coref-ident | NF-kappaB activation,NF-kappaB activation |
| R8 | C17 | C11 | coref-ident | a soluble peptide inhibitor,a soluble peptide inhibitor |
| R9 | C19 | C8 | coref-ident | p50 and p65,the NF-kappaB subunits p50 and p65 |
| R10 | C20 | C18 | coref-ident | TCR-mediated apoptosis,TCR-mediated apoptosis |
| R11 | C23 | C22 | coref-relat | that,mice |
| R12 | C24 | C15 | coref-ident | Fas-mediated apoptosis,Fas-mediated apoptosis |
| R13 | C25 | C3 | coref-ident | TNF,TNF |
| R14 | C27 | C25 | coref-pron | itself,TNF |
| R15 | C28 | C4 | coref-ident | NF-kappaB,NF-kappaB |
| R16 | C26 | C25 | coref-appos | itself a positive regulator of NF-kappaB,TNF |
| R17 | C29 | C21 | coref-ident | the cells,primary T cells |
| R18 | C31 | C30 | coref-relat | that,compelling evidence |
| R19 | C32 | C28 | coref-ident | NF-kappaB,NF-kappaB |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | protein_complex | denotes | NF-kappaB |
| T2 | 67-80 | cell_type | denotes | T lymphocytes |
| T3 | 101-123 | other_name | denotes | lymphocyte homeostasis |
| T4 | 127-136 | other_name | denotes | apoptosis |
| T5 | 142-171 | other_name | denotes | critical regulatory mechanism |
| T6 | 179-199 | body_part | denotes | normal immune system |
| T7 | 205-225 | protein_family_or_group | denotes | transcription factor |
| T8 | 226-235 | protein_complex | denotes | NF-kappaB |
| T9 | 312-315 | protein_family_or_group | denotes | TNF |
| T10 | 334-343 | protein_complex | denotes | NF-kappaB |
| T11 | 374-377 | protein_molecule | denotes | Fas |
| T12 | 378-383 | protein_molecule | denotes | APO-1 |
| T13 | 384-388 | protein_molecule | denotes | CD95 |
| T14 | 424-441 | cell_type | denotes | peripheral T cell |
| T15 | 465-477 | cell_line | denotes | Jurkat cells |
| T16 | 487-505 | protein_subunit | denotes | NF-kappaB subunits |
| T17 | 506-509 | protein_subunit | denotes | p50 |
| T18 | 514-517 | protein_subunit | denotes | p65 |
| T19 | 545-557 | other_name | denotes | Fas-mediated |
| T20 | 558-567 | other_name | denotes | apoptosis |
| T21 | 597-606 | protein_complex | denotes | NF-kappaB |
| T22 | 623-638 | peptide | denotes | soluble peptide |
| T23 | 675-684 | protein_complex | denotes | NF-kappaB |
| T24 | 696-703 | protein_molecule | denotes | IkappaB |
| T25 | 741-753 | other_name | denotes | Fas-mediated |
| T26 | 754-763 | other_name | denotes | apoptosis |
| T27 | 792-801 | protein_complex | denotes | NF-kappaB |
| T28 | 855-871 | cell_line | denotes | T cell hybridoma |
| T29 | 892-904 | other_name | denotes | TCR-mediated |
| T30 | 905-914 | other_name | denotes | apoptosis |
| T31 | 949-952 | protein_subunit | denotes | p50 |
| T32 | 957-960 | protein_subunit | denotes | p65 |
| T33 | 1012-1021 | other_name | denotes | apoptosis |
| T34 | 1074-1077 | protein_molecule | denotes | Fas |
| T35 | 1096-1111 | cell_type | denotes | primary T cells |
| T36 | 1113-1127 | other_organic_compound | denotes | Concanavalin A |
| T37 | 1138-1159 | cell_line | denotes | cycling T cell blasts |
| T38 | 1165-1169 | multi_cell | denotes | mice |
| T39 | 1198-1206 | protein_molecule | denotes | dominant |
| T40 | 1207-1214 | protein_molecule | denotes | IkappaB |
| T41 | 1254-1266 | other_name | denotes | Fas-mediated |
| T42 | 1267-1276 | other_name | denotes | apoptosis |
| T43 | 1296-1311 | other_name | denotes | down-regulation |
| T44 | 1315-1324 | protein_complex | denotes | NF-kappaB |
| T45 | 1373-1376 | protein_family_or_group | denotes | TNF |
| T46 | 1409-1418 | protein_complex | denotes | NF-kappaB |
| T47 | 1425-1448 | protein_family_or_group | denotes | neutralizing antibodies |
| T48 | 1487-1504 | other_name | denotes | anti-Fas-mediated |
| T49 | 1505-1514 | other_name | denotes | apoptosis |
| T50 | 1573-1582 | protein_complex | denotes | NF-kappaB |
| T51 | 1600-1603 | protein_molecule | denotes | Fas |
| T52 | 1665-1683 | other_name | denotes | T cell homeostasis |
| T53 | 1688-1697 | other_name | denotes | tolerance |